PharmaCaribe specializes in hypertonic saline inhalation therapy. We currently offer two different formulation lines of saline products.

In 2013, the FDA cleared our 2nd Generation bio-balanced™ patent pending formulation in six concentrations. The patent pending formulations of our hypertonic saline are buffered with sodium bicarbonate to a pH of 7.4 (pH+)

FDA cleared in 2010 a line of 5 concentrations of hypertonic saline manufactured strictly to USP guidelines. Currently commercially available in concentrations of 7%, 6% and 3% salinity.

Find out more information about ordering PharmaCaribe products through various distributors.